Do sulphonylureas still have a place in clinical practice?

Sulphonylureas have been commercially available since the 1950s, but their use continues to be associated with controversy. Although adverse cardiovascular outcomes in some observational studies have raised concerns about sulphonylureas, findings from relatively recent, robust, and high-quality syst...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet. Diabetes & endocrinology 2018-10, Vol.6 (10), p.821-832
Hauptverfasser:	Khunti, Kamlesh, Chatterjee, Sudesna, Gerstein, Hertzel C, Zoungas, Sophia, Davies, Melanie J
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular Diseases - chemically induced Cardiovascular Diseases - complications Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - adverse effects Randomized Controlled Trials as Topic Risk Factors Sulfonylurea Compounds - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!